期刊文献+

细胞块上检测P16、HPV16用于筛查ASCUS中高度宫颈上皮内瘤变的临床探讨 被引量:3

The significance of detecting P16,HPV16 expression in cervical deciduous cells on cell block of ASCUS to identify high grade squamous intraepithelial neoplasia
下载PDF
导出
摘要 目的探讨利用细胞块技术,检测宫颈脱落细胞P16、HPV16表达在筛查ASCUS中高度宫颈上皮内瘤变的意义。方法选取TCT检测为ASCUS的120例患者,所有患者均行阴道镜下宫颈活检,取其TCT保存液中的剩余物质制备宫颈细胞块,然后,在细胞块上进行P16、HPV16免疫组化染色。结果1)120例ASCUS患者经阴道镜下宫颈活检病理学诊断结果为:宫颈炎64例,CINⅠ33例,CINⅡ17例,CINⅢ16例,其中高度宫颈上皮内瘤变者(CINⅡ、CINⅢ)为23例,占19.17%。2)ASCUS中P16阳性表达在宫颈炎组、CINⅠ组、CINⅡ组、CINⅢ组分别为6.25%、51.52%、82.35%、83.33%。P16阳性表达率在宫颈炎组与CINⅠ组,CINⅡ组,CINⅢ组之间比较均有显著性差异(P<0.01)。以P16强阳性表达为判定标准,则检出高度宫颈上皮内瘤变的敏感性、特异性、阳性预测值、阴性预测值分别为78.26%、92.78%、72%、94.74%。3)ASCUS中HPV16阳性表达率在宫颈炎组、CINⅠ组、CINⅡ组、CINⅢ组分别为21.88%、39.39%、76.47%、83.33%,HPV16阳性表达率在宫颈炎组与CINⅡ组、CINⅢ组,CINⅠ组与高度宫颈上皮内瘤变组之间比较,均有显著性差异(P<0.01)。结论细胞块上检测P16,HPV16可用于ASCUS中高度宫颈上皮内瘤变筛查。 Objective To access the significance of detecting P16 and HPV16 expression in ASCUS to identify high grade squamous intraepithelial neoplasia. Methods Selected 120 patients with atypical squamous cells of undetermined significance after thinprep cericovaginal cytology examination and they were done cervical biopsy under the colposcope. Cell block be prepared from residual material of thinprep preserve solution, cell block section were immunostained with antibody P16n protein and antibody HPV16. Results (1) The result of being done cervicel biopsy under the colposcope were as follow: cervicitis in 64 specimens, CIN Ⅰ in 33 specimens, Cin Ⅱ in 17 specimens, C1NⅢ in 6 specimens, in these cases there were 19.17% high grade squamous intraepithelial neoplasia (CINⅡ, CINⅢ).(2)Positive rate of immunostaining for P16 on cervical deciduous cells in cervicitis,CIN Ⅰ , CIN Ⅱ ,CINⅢ were 6.25%,51.52%,82.35%,83.33%, respectively. Immunostaining for P16 between eervicitis and C1NⅠ, cervicitis and CINⅡ, cervicitis and CINⅢ exhibited statistically significant associations (P〈0.01). Assessment aaccording to the standard of intense expression, The sensitivity,the specificity,positive predictive value and negative predictive value for immunostaining of cervical deciduous cells for P16 to detect high grade squamous intraepithelial neoplasia was respectively 78.26% ,92.78% ,72% ,94.74%.(3) Positive rate of immunostaining of HPV16 on cervical deciduous cells in cervicitis,CINⅠ ,CINⅡ ,CINⅢ were 21.88%,39.39%,76.47%,83.33%, respectively. Immunostaining for HPV16 between cervicitis and CIN Ⅰ ,cervicitis and CINⅢ ,CINⅠ and high grade squamous intraepithelial neoplasia exhibited statistically significant association(P〈0.01). Conclusion Detecting P16 and HPV16 expression in SACUS can identify the high grade squamous intraepithelial neeplasia.
出处 《海南医学》 CAS 2008年第9期15-18,共4页 Hainan Medical Journal
关键词 未明确意义的非典型鳞状细胞 P16 人乳头状瘤病毒16 鳞状上皮内瘤样变 免疫组化 Atypical squamous ceils of undetermined significance P16 HPV16 Cervical squamous intraepithelial neoplasia Immunohistochemistry
  • 相关文献

参考文献10

  • 1Kamb A. A cell cycle regulator potentially involved in the genesis of many tumor type [J]. Science 1994,264:436-440.
  • 2Murphy N, Ring M, Killalea AG, et al. P16ink4A as a marker for cervical dyskaryosis: CIN and e GIN in cervical biopsies and Thinprep smears [J]. J Clin Pathol, 2003,5,6(1):56-63.
  • 3Nieh S, Chen SF, Chu TY, et al. Is P16 expression more useful titan human papillomavirus test to determine the outcome of atypical squamous cells of undermined significance-categorized Pap smears[J]. Gynecol oncol, 2005,97(1):35-40.
  • 4Dray M, Russell P, Dalrymple C. et al. P16ink4a as a complementary marker of high grade intraepithelial lesion of the uterine cervix, 1:experience with squamous lesion of the in 189 consecutive cervical biopsies. Pathology, 2005,37(2):112-124.
  • 5邹先进,蔡兰,刘颖,王梅,谢军花.子宫颈癌前病变与子宫颈癌组织中p16^(INK4A)蛋白检测及其与人乳头状瘤病毒感染的关系[J].中华妇产科杂志,2004,39(9):625-626. 被引量:25
  • 6Adersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical carcinoma carcinogenesis. European Cancer, 2001,37:246-250.
  • 7孙瑞珍,郑茂荣,肖正达.宫颈高危型HPV感染后恶性转化及干预[J].国外医学(肿瘤学分册),2004,31(4):303-305. 被引量:2
  • 8Kanao H, Enomoto T, Ueda Y, et al. Correction between P14/P16ink4a expression and HPV infection in uterine cervical cancer. Cancer Lett, 2004,213( 1):31-37.
  • 9Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squsmous cell of undetermined significance: baseline results from a randomized trial. J Natt Cancer Inset, 2001,93:293-299.
  • 10Akpolat I, Smith DA, Ramzy I, et al. The utility of P16ink4a and cell block prepared from residual Thin -layer cervicovaginal material. Cancer, 2004,102(3): 142-149.

二级参考文献18

  • 1Chou RH,Huang H. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite. Biochem Biophys Res Commun, 2002,293(1): 298-306.
  • 2Niwa K, Tagami K, Lian Z, et al. Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions. Oncol Rep, 2003,10(5): 1437-1441.
  • 3Kay P, Soeters R, Nevin J, et al. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia . J Med Virol, 2003, 71(2): 265-273.
  • 4Horn LC, Raptis G, Fischer U. Familial cancer history in patients with carcinoma of the cervix uteri. Eur J Obstet Gynecol Reprod Biol, 2002,101 (1): 54-57.
  • 5Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer, 2003,106(3): 396-403.
  • 6Cruickshank ME, Sharp L, Chambers G, et al. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG, 2002,109 ( 5 ): 579-581.
  • 7Furumoto H, Irahara M. Human papilloma virus (HPV) and cervical cancer. J Med Invest, 2002,49(3-4):124-133.
  • 8Filippova M, Song H, Connolly JL, et al. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. JBiol Chem, 2002, 277(24) :21730-21739.
  • 9Crum CP, Abbott DW, Quade BJ. Cervical cancer screening: from the papanicolaou smear to the vaccine era. J Clin Oncol, 2003, 21(90100): 224 - 230.
  • 10Eiben GL, da Silva DM, Fausch SC, et al. Cervical cancer vaccines: recent advances in HPV research. Viral Immunol, 2003,16(2): 111-121.

共引文献25

同被引文献22

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部